Vitreous Carbon Foam

THE TECHNOLOGY

Regenerative medicine, in which therapeutics, devices and repair cells are applied to help the body heal itself, is,currently one of the fastest growing areas of medical practice. The clinical impact of these new initiatives, however,has been constrained owing to a lack of materials and suitable geometries that fulfill the mandates of safety,efficacy, ease of use and cost-effectiveness. The present application draws attention to particulate materials derived from controlled breakage of vitreous carbon foam constructs as a platform technology for multiple medical procedures performed to address diverse tissue deficits and/or pathologies. The results of these studies have revealed that particulate vitreous carbon foam-derived particles are biocompatible, permissive of cell attachment and differentiation, bind regenerative-important growth factors in an active elutable form, and provide a 3-dimensional substrate that is permissive of neo-vascularization.

BENEFITS

  • Increased surgical options
  • Favorable clinical outcomes with fewer revision surgeries
  • Improvement of patient care
  • Reduced out-of-pocket expense

APPLICATIONS

  • Spinal fusion
  • General orthopedics
  • Vertebroplasty
  • Wound care

OPPORTUNITY

  • Available for license/purchase and patent-pending
  • Potential for ongoing collaboration with inventors Stephen Miller, Nora Strong, and Joel White
Vitreous

QUICK INFO
Inventor(s):
  • Stephen Miller
  • Nora Strong
  • Joel White

Reference Number:
15V125

Download a Printable PDF

CONTACT
Becky Hundley
Contracts & Intellectual Property Manager
becky.hundley@wichita.edu
316.978.5199